Interferon alpha-induced depression in chronic hepatitis C patients: Comparison between different types of interferon alpha

Neuropsychobiology

Volumn 37, Issue 2, 1998, Pages 93-97

  Malaguarnera, M ^a,b   Di Fazio, I ^a   Restuccia, S ^a   Pistone, G ^a   Ferlito, L ^a   Rampello, L ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b NONE   (Italy)

Author keywords

Chronic hepatitis; Interferon alpha; Self rating depression scale

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON A; ANTIVIRUS AGENT; LYMPHOBLAST INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SELF EVALUATION;

AGED; ANTIVIRAL AGENTS; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; INTERFERON TYPE I, RECOMBINANT; INTERFERON-ALPHA; MALE; PSYCHIATRIC STATUS RATING SCALES;

EID: 0031914489     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026485     Document Type: Article

References (13)

1. Hardy P: Depressive disorders and Interferon alpha. Gastroenterol Clin Biol 1996;20:255-257.
2. Janssen HL, Brouwer JT, Van der Mast RC, Schalm SW: Suicide associated with alpha-interferon therapy for chronic viral hepatitis. J Hepatol 1994;21:241-243.
3. Renault PF, Hoofnagle JH, Park Y, Mullen KD, Peters M, Jones DB, et al: Psychiatric complication of long term interferon alpha therapy. Arch Intern Med 1987;147:1557-1580.
4. Malaguarnera M, Pistone G, Trovato BA, Panebianco P, Rampello L: Impaired thermal and tactile sensitivity during alpha interferon treatment. Clin Drug Invest 1996;12:271-273.
5. Malaguarnera M, Pistone G, Trovato BA. Siciliano R, Marletta C, Motta M, Restuccia S, Marietta F: Mapped auditory evoked potentials before and after interferon treatment. J Interferon Cytokine Res 1996;16:441-446.
6. Torp-Pedersen S, Vyberg M, Smith E, et al: Surecut 0.6 mm liver biopsy in the diagnosis of cirrhosis, Liver 1990;10:217-220.
7. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuder PJ; Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994;19:1513-1520.
8. Zung WWK: A self-rating depression scale. Arch Gen Psychiatry 1965;12:63-68.
9. Meyers CA, Scheibel RS, Forman AD: Persistent neurotoxicity of systemically administered interferon-alpha. Neurology 1991;41:672-676.
10. Rampello L, Nicoletti G, Raffaele R, Drago F: Comparative effects of amitrypline and amineptine in patients affected by anxious depression. Neuropsychobiology 1995;31:130-134.
11. Forman AD: Neurologic complications of cytokine therapy. Oncology 1994;8:105-110.
12. Rothstein JD: Benzodiazepine-receptor ligands and hepatic hencephalopathy: A causal relationship? Hepatology 1994;19:248-250.
13. Levenson JL, Fallon HJ: Fluoxetine of depression caused by interferon-alpha. Am J Gastroenterol 1993;88:760-761.